bovnews12m
What’s Driving Sarepta Therapeutics Inc (SRPT) Stock’s -4.66% Plunge Over the Past Month?
On Thursday, Sarepta Therapeutics Inc (SRPT) stock saw a modest uptick, ending the day at $122.41 which represents a slight increase of $4.42 or 3.75% from the prior close of $117.99. The stock opened ...
Arkansas Times16h
Paper-ballot proponents largely unsuccessful in ballot access lawsuits
Supporters of the Arkansas Voter Integrity Initiative filed nine lawsuits and only won two, both of which could still be ...
Nucleic Acid Therapeutics CDMO Industry Outlook, 2024-2030 - Increasing Demand for One-Stop-Shop CDMOs and Growing FDIs in Nucleic Acid Therapeutics
The "Nucleic Acid Therapeutics CDMO Market Size, Share & Trends Analysis, 2024-2030" report has been added to ...
STAT22h
Sarepta’s gene therapy is fully approved, but its stock has tanked. Here’s why
Since the FDA cleared Sarepta Thereapeutics' gene therapy for nearly all people with Duchenne, its stock price has tanked.